Epoprostenol (prostacyclin): Difference between revisions
ClaireLewis (talk | contribs) No edit summary |
No edit summary |
||
Line 47: | Line 47: | ||
==See Also== | ==See Also== | ||
[[Pulmonary Hypertension]] | |||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] |
Revision as of 00:28, 3 August 2016
Epoprostenol = prostacyclin (naturally-occurring PGI2) in medication form
Administration
- Type: Prostaglandin
- Dosage Forms:
- Routes of Administration: IV, nebulized
- Common Trade Names: Flolan
Adult Dosing
- IV: 2 ng/kg/min initially, titrate upward by 2 ng/kg/min q15m until intolerance or dose-limiting effects occur. Avoid abrupt withdrawal: gradually decrease dose by 2ng/kg/min q15min.
- Nebulized: dosing not well standardized, usually 12.5-50 ng/kg/min
Pediatric Dosing
Safety/efficacy not well established (though some PICUs do use it)
Special Populations
- Pregnancy Rating: B
- Lactation risk: Infant risk cannot be ruled out
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
- LV failure
Adverse Reactions
Serious
- Hemorrhage
- Hypersplenism
- Infection
Common
- Tachycardia, bradyarrythmia
- Hypotension
- Nausea/vomiting, diarrhea, abdominal pain
- Flushing
- Headache, dizziness
- Musculoskeletal pain
Pharmacology
- Half-life: ~6 min
- Metabolism: Extensively and rapidly metabolized in blood
- Excretion: Mostly renal
Mechanism of Action
- Prostaglandin--> stimulates vasodilation of pulmonary and systemic arteries. Also inhibits platelet aggregation.